Metagenomic and Immune-inflammatory Analysis of Individuals With Generalized Aggressive Periodontitis and Their Descendants.

Overview

Generalized aggressive periodontitis (GAgP) is a multifactorial disease related to several aspects that influence its installation and progression. A constant microbial colonization, an altered inflammatory response, and a clear genetic factor are cited as possible factors associated with this pathology. Thus, aggressive periodontitis subjects could transmit for their descendants some genetical alterations, such as inflammatory response pattern associated with periodontal destruction and susceptibility to colonization by some pathogens, increasing the risk of develops this disease. This way, this project is aimed to evaluate the pattern of microbiological colonization and the inflammatory response pattern associated with it, comparing parents with generalized aggressive periodontitis and their children and periodontally healthy parents and their children. Thirty families will be selected and divided into two groups: Test group (n=15 families) families in which the parents (or at least one of them) present generalized aggressive periodontitis and one child (age ranging from 6-12 years old); Control group (n=15 families) families in which the parents (both of them) present periodontal healthy and one child (age ranging from 6-12 years old). The groups will be composed using a gender- and age-matched structure. The children will participate in a hygiene program and will be monitored for 3 months. All individuals (parents and children) will be clinically assessed for plaque and bleeding index, periodontal probing depth, clinical attachment level and gingival recession. During this period, samples of gingival crevicular fluid (GCF) and subgingival biofilm from periodontal pockets/sites from all subject (parents and children) will be collected. The GCF will be analyzed and the detection of interleukin (IL)-1β, IL-4, IL-6, IL-8, IL-10, IL-17, tumor necrosis factor (TNF)-α, and interferon (INF)-γ will be done using Luminex/MAGpix technology. In a subgingival biofilm, the DNA will be extracted and the microbiome and its functional characteristics will be evaluated by metagenomics and bioinformatics analysis. The data will be compared by Student's t-test, Mann-Whitney e Wilcoxon tests. The significance level for all analysis will be 5%.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Other
  • Study Primary Completion Date: December 15, 2016

Interventions

  • Other: Plaque control
    • Children were instructed about the hygiene procedures

Arms, Groups and Cohorts

  • GAgP parents
    • Parents diagnosed with Generalized Aggressive Periodontitis
  • GAgP children
    • Children from parents diagnosed with Generalized Aggressive Periodontitis
  • Health parents
    • Parents diagnosed as periodontally healthy
  • Health children
    • children from parents diagnosed as periodontally healthy

Clinical Trial Outcome Measures

Primary Measures

  • Change of the baseline plaque index on probing at 3 months
    • Time Frame: Baseline and 3 months for each test
    • Reduction in the amount of plaque accumulation around the gingival marginal after the therapy.

Secondary Measures

  • Change of the baseline bleeding on probing at 3 months
    • Time Frame: Baseline and 3 months for each test
    • Bleeding induced at the depth of the gingival sulcus or periodontal pocket after probing
  • Change of the baseline inflammatory markers levels in gingival crevicular fluid (pg/uL) at 3 months
    • Time Frame: Baseline and 3 months for each test
    • Concentration of IL-1β, IL-4, IL-6, IL-8, IL-10, IL-17, TNF-α and INF-γ released in gingival crevicular fluid
  • Change in the microbial composition at 3 months
    • Time Frame: Baseline and 45 days for each test
    • Concentration of bacteria in the subgingival biofilm

Participating in This Clinical Trial

Inclusion Criteria

  • GAgP parents: i) less than 35 years old at the diagnosis; ii) at least 8 teeth with probing depth (PD) and clinical attachment level (CAL) > 5mm (with at least 2 sites with PD > 7mm) at diagnosis; iii) at least 20 teeth in the oral cavity; iv) good systemic health. – Health parents: i) Good systemic health; ii) at least 20 teeth in the oral cavity; iii) absence of periodontal pockets/gingival sulcus with PD > 4mm; iv) absence of proximal bone loss. – Children: i) to present parents respecting the inclusion criteria for periodontal health or GAgP; ii) 6 to 12 years of age at the beginning of study iii) good systemic health iv) presence of first molars and central incisors. Exclusion Criteria – the use of antibiotics and anti-inflammatory medication 6 months prior to the study; – smoking habits – pregnancy or lactation.

Gender Eligibility: All

Minimum Age: 6 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of Campinas, Brazil
  • Provider of Information About this Clinical Study
    • Principal Investigator: Renato Casarin, Professor Dr. – University of Campinas, Brazil

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.